eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
5/2007
vol. 24
 
Share:
Share:
abstract:

Original paper
Impact of phototherapy on selected lipid profile indices in psoriatic patients allowing

Ewa Hadas
,
Andrzej Bożek
,
Jerzy Jarząb

Post Dermatol Alergol 2007; XXIV, 5: 215–223
Online publish date: 2007/10/22
View full text Get citation
 
Psoriasis is a chronic inflammatory skin disease, which is often accompanied by lipid metabolism disorders related to an increased risk of sclerosis development. The study aimed at assessing concentrations of selected lipid profile indices, oxidation markers and the efficiency of antioxidant defence in psoriatic patients with different intensification of pathological lesions before and after phototherapy treatment. On the basis of calculated PASI score the patients were divided into two 30-person groups: PASI 1 (from 5.4 to 22.1, mean 15.2±4.9), and PASI 2 (from 22.5 to 49.20, mean 30.3±5.8). All patients underwent 10 therapies using one of three phototherapy methods (UVA, UVB, UVB 311 nm). The analysis of acquired data showed the proatherogenic nature of lipid profile in psoriatic patients with a more severe course of disease. Increased skin manifestations of psoriasis are accompanied by an increase of dyslipidaemia and oxidation processes. However, the lesions are not visibly modified by phototherapy, which allows one to conclude that phototherapy treatment of 10 cycles is safe, and it does not increase sclerosis risk in psoriatic patients.
keywords:

psoriasis, phototherapy, serum lipid profile, oxidatively modified low-density lipoprotein (oxLDL), autoantibodies against oxidatively modified LDL (auAb-ox LDL), ferric reducing ability of plasma (FRAP), PASI score

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.